BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29522072)

  • 1. Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer.
    Harris JP; Chen MM; Orosco RK; Sirjani D; Divi V; Hara W
    JAMA Otolaryngol Head Neck Surg; 2018 Apr; 144(4):349-359. PubMed ID: 29522072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
    George JR; Yom SS; Wang SJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
    Kao J; Lavaf A; Teng MS; Huang D; Genden EM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Avkshtol V; Handorf EA; Ridge JA; Leachman BK; Liu JC; Bauman J; Galloway TJ
    Head Neck; 2019 Jul; 41(7):2133-2142. PubMed ID: 30737968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
    Mohan S; Pai SI; Bhattacharyya N
    Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
    JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
    Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL
    Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
    Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
    Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
    Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated or accelerated radiotherapy for head and neck cancer.
    Baujat B; Bourhis J; Blanchard P; Overgaard J; Ang KK; Saunders M; Le Maître A; Bernier J; Horiot JC; Maillard E; Pajak TF; Poulsen MG; Bourredjem A; O'Sullivan B; Dobrowsky W; Andrzej H; Skladowski K; Hay JH; Pinto LH; Fu KK; Fallai C; Sylvester R; Pignon JP;
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD002026. PubMed ID: 21154350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
    Lacas B; Bourhis J; Overgaard J; Zhang Q; Grégoire V; Nankivell M; Zackrisson B; Szutkowski Z; Suwiński R; Poulsen M; O'Sullivan B; Corvò R; Laskar SG; Fallai C; Yamazaki H; Dobrowsky W; Cho KH; Beadle B; Langendijk JA; Viegas CMP; Hay J; Lotayef M; Parmar MKB; Aupérin A; van Herpen C; Maingon P; Trotti AM; Grau C; Pignon JP; Blanchard P;
    Lancet Oncol; 2017 Sep; 18(9):1221-1237. PubMed ID: 28757375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck.
    Rosenthal DI; Liu L; Lee JH; Vapiwala N; Chalian AA; Weinstein GS; Chilian I; Weber RS; Machtay M
    Head Neck; 2002 Feb; 24(2):115-26. PubMed ID: 11891941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of treatment package time on survival in surgically managed head and neck cancer in the United States.
    Goel AN; Frangos MI; Raghavan G; Lazaro SL; Tang B; Chhetri DK; Long JL; St John MA
    Oral Oncol; 2019 Jan; 88():39-48. PubMed ID: 30616795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.
    Puc MM; Chrzanowski FA; Tran HS; Liu L; Glicksman AS; Landman C; Slotman GJ
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):337-42. PubMed ID: 10722006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.